Data as of 3:59pm ET
| -0.05 / -2.84%|
The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 2.25, with a high estimate of 2.25 and a low estimate of 2.25. The median estimate represents a +31.58% increase from the last price of 1.71.
The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.